Trial
NCT07523009
CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Peking Union Medical College Hospital
Collaborators
—
Condition
Severe Aplastic Anemia (SAA)
Intervention
Cyclosporine (CsA)
Why stopped
The registration of this research plan was incorrect. A new registration has been re-applied for.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04